Pivot Bio, Inc. announced that it has received $430,000,000 in a round of funding co-led by returning investors Data Collective and Temasek Capital Management Pte. Ltd. on July 19, 2021. The transaction included participation from new investors Generation Investment Management LLP, G2 Groupe, LLC, Venture Capital Arm, Rockefeller Capital Management L.P. and returning investors Continental Grain Company Corp., Bunge Limited, Pavilion Capital Partners LLC, Prelude Ventures, LLC, Breakthrough Energy Ventures, LLC, Tekfen Ventures and individual investor Roger Underwood. The company issued common stock in the transaction. The company has raised more than $600,000,000 in funding till date. The round is raised at a post-money valuation of nearly $2,000,000,000.